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Abstract
The exact mechanisms and temporal sequence of neurodegeneration in multiple sclerosis are still unresolved. The
visual pathway including its unmyelinated retinal axons, can serve as a prototypic model of neurodegeneration in
experimental optic neuritis. We conducted a longitudinal study combining retinal imaging through optical
coherence tomography (OCT) with immunohistochemical analyses of retinal and optic nerve tissue at various time
points in experimental autoimmune encephalomyelitis (EAE).
Inner retinal layer (IRL) thickness was measured in 30 EAE and 14 healthy control C57BL/6 J mice using OCT.
Distribution of marker proteins was assessed by immunofluorescence staining and retinal mRNA levels were
assayed using real-time PCR. Histological morphology was evaluated on light and electron microscopy images.
Signs of inflammatory edema 11 days post immunisation coincided with IRL thickening, while neuro-axonal
degeneration throughout the disease course contributed to IRL thinning observed after 20 days post immunisation.
Retinal pathology, including axonal transport impairment, was observed early, prior to cellular infiltration (i.e. T-cells)
in the optic nerve 11 days post immunisation. Yet, the effects of early retinal damage on OCT-derived readouts
were outweighed by the initial inflammatory edema. Early microglial activation and astrocytosis was detected in the
retina prior to retinal ganglion cell loss and persisted until 33 days post immunisation. Müller cell reactivity (i.e.
aquaporin-4 and glutamine synthetase decrease) presented after 11 days post immunisation in the IRL. Severe
neuro-axonal degeneration was observed in the optic nerve and retina until 33 days post immunisation.
Initial signs of retinal pathology subsequent to early glial activity, suggests a need for prophylactic treatment of
optic neuritis. Following early inflammation, Müller cells possibly respond to retinal pathology with compensatory
mechanisms. Although the majority of the IRL damage observed is likely due to retrograde degeneration following
optic neuritis, initial pathology, possibly due to gliosis, may contribute further to IRL thinning. These results add
morphological substrate to our OCT findings. The extent and rapid onset of axonal and neuronal damage in this
model appears relevant for testing interventions scaled to human optic neuritis.
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Introduction
Neurodegeneration is a key factor for irreversible disabil-
ity observed in multiple sclerosis (MS) [1]. Although
previously thought to be a consequence of inflammatory
mediated myelin loss, neurodegeneration independent of
demyelination has been observed in both murine models
of MS [2, 3] and human post-mortem retinal tissue [4].
Neurodegeneration in the afferent visual pathway is
prevalent in MS, most frequently following optic neuritis
(ON; an inflammation of the optic nerve) and often
resulting in functional visual impairment that can persist
even after treatment [5, 6]. Damage from the optic nerve
can propagate into the retina, by processes of retrograde
degeneration, contributing to visual impairment observed
in MS [7].
Similar to findings in human studies, alterations in the
retina [8, 9], optic nerve [10–13], tract [11, 12], chiasm
[14], and radiations [15] have been reported in mouse
models of MS. Approximately 70–92% of eyes develop
ON 11 days post immunisation (dpi) in experimental
ON mouse models, making it ideal for investigating
visual pathway dysfunction [11, 16, 17]. Although nu-
merous target autoantigens exist for murine models of
MS, myelin oligodendrocyte glycoprotein (MOG) in-
duced experimental autoimmune encephalomyelitis
(EAE) appears to have predilections for optic tract path-
ology and often results in the development of bilateral
ON [18]. For example, MOG-specific T-cells induce a
greater density of lesions in the optic nerve compared to
other models such as myelin basic protein (MBP) in-
duced EAE [18]. Moreover, murine and human retinas
share many commonalities including comparable retinal
layers with the primary difference being generally thin-
ner layers and the lack of a macula in mice [19].
Optical coherence tomography (OCT) is a rapidly
evolving, non-invasive imaging technique that has be-
come a prominent tool in MS research. OCT not only
assesses structural injury in the visual system, frequently
affected in MS, but can also be utilized as a powerful
marker for more global central nervous system (CNS)
neurodegeneration [20]. The inner retinal layer (IRL) in-
cludes the unmyelinated axons, cell bodies, and den-
drites of the third level CNS retinal neurons, retinal
ganglion cells (RGC), which can be quantified using
OCT. This is ideal for assessing neuro-axonal degener-
ation independent of demyelination and might constitute
a beneficial model for testing treatments targeting neu-
rodegeneration specifically. Furthermore, numerous
studies have found significant associations between OCT
measures of retinal atrophy and magnetic resonance im-
aging detected brain tissue loss both globally, [21–23]
and within the visual pathway [24–27], further solidify-
ing the potential of OCT for the assessment of CNS
neurodegeneration in MS.
Several studies have assessed retinal pathology using
OCT in experimental models of ON [3, 11, 16, 28–32].
In particular, studies have revealed initial phases of IRL
thickening [11, 31] around the optic nerve head (ONH)
followed by severe thinning at later stages of the disease
in EAE mice compared to healthy controls [16]. This
resembles what has been observed in some cases of MS-
related acute ON, with an initial phase of swelling in the
peripapillary retinal nerve fiber layer (pRNFL) that di-
minishes over time, revealing severe degeneration or
thinning [33, 34].
Regardless of the prominent use of OCT in MS and
ON research, it remains uncertain what the changes in
IRL thickness indicate in the context of pathological
processes. Few studies have attempted to associate OCT
derived retinal layer findings with anatomical correlates
[35, 36], however, the topic has only been marginally ex-
plored and it is still not clear how MS pathology might
affect the inner retina. Currently, it is assumed that in-
creases in pRNFL thickness in human acute-ON or IRL
thickness in EAE are due to edema related to the inflam-
matory autoimmune response on the myelinated portion
of the optic nerve in early stages, whereas, IRL thinning
observed later in the disease is thought to reflect axonal
loss, neurodegeneration, or retrograde degeneration fol-
lowing ON. However, these speculations are based pri-
marily on correlation studies in humans [25, 37, 38].
Furthermore, thickness changes in the inner nuclear
layer (INL) and outer plexiform layer (OPL) are rela-
tively unexplored in mouse models of MS, including
how these changes might relate to Müller cell reactivity.
Therefore, the objective of the current study was to
add structural meaning to OCT findings using immuno-
histochemical analyses of tissue specimen and to explore
the biological mechanisms of visual pathway damage in
experimental ON longitudinally.
Materials & methods
Mice and EAE induction
Studies were performed in conformity with the Swiss
Animal Welfare Law (License No.: 078/15). A total of 44
female 16–18 weeks old C57BL/6JRj (Janvier, Le Genest-
St Isle, France) [39, 40] mice were examined in this
study. EAE was induced in 30 mice by immunisation
with an emulsion of MOG35–55 (Hooke Laboratories,
Lawrence, MA, USA), in complete Freund’s adjuvant
(CFA), injected subcutaneously into both flanks (0.2 mg/
mouse), followed by intraperitoneal administration of
pertussis toxin in phosphate-buffered saline (PBS) on
day 0 of immunisation and again on day 1 (4 μg/mL/
mouse/day). Animals were weighed and observed/scored
daily after showing the first signs of symptoms, as
assessed by the EAE disability score (0 = no detectable
signs of EAE, 0.5 = distal limp tail, 1 = complete limp tail,
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1.5 = limp tail and hind limp weakness, 2.0 = unilateral
partial hind limb paralysis, 2.5 = bilateral partial hind
limb paralysis, 3.0 = complete bilateral hind limb paraly-
sis, 3.5 = complete bilateral hind limb paralysis and par-
tial forelimb paralysis, 4.0 =moribund, 5.0 = death). All
mice had access to food and water ad libitum and were
housed in a light-dark cycle of 12:12 h. Directly after
EAE induction, food and water was placed on the cage
floor to facilitate food and water intake of disabled ani-
mals. To reduce artificial light related damage to the
eyes, all cages were kept on the same rack/level with the
same distance from light sources (furthest away) and
provided red houses.
OCT assessment
The OCT methodology is reported in line with the APOS-
TEL recommendations [41]. A Spectralis® OCT-2 Plus de-
vice (Heidelberg Engineering, Heidelberg, Germany) was
utilized for the OCT assessment and operated by a single
user (P.M.). The device is equipped with a TruTrack® eye
tracking program that ensures exact repositioning of the
laser beam and optimizes reliability of repeated, longitu-
dinal measurements. To adapt the system for mice im-
aging, a commercially available lens (25 diopter) was fitted
to the system. Anesthesia was induced with 3.0% isoflur-
ane (Piramal Healthcare Limited, India) in a 1:2 O2/air
mixture. Anesthesia was then reduced to 2.0% isoflurane
in a 1:2 O2/air mixture for the remainder of the examin-
ation while the animals were spontaneously breathing.
The pupils of both eyes were dilated (Mydriaticum Dis-
persa; Tropicamidum 5mg/ml, OmniVision, Neuhausen,
Switzerland) prior to the examination. Animals were
placed on a custom-built positioning device with an inte-
grated water heating system to avoid hypothermia. Ocular
lubrication was maintained using a gel (Lacrinorm; Carbo-
merum 980 2mg/ml, Bausch & Lomb Swiss AG, Zug,
Switzerland) and a vendor supplied atraumatic focal con-
tact lens was placed over the eye to improve image acqui-
sition quality.
Horizontal and vertical line scans were used for position-
ing the scan protocol over the ONH in the center of the
fundus image. OCT measurements were obtained under
ambient light conditions with a focus distance of 40 diop-
ters. A high-resolution volume scan was performed over
the ONH involving 25 consecutive horizontal B-scans
(148 μm between B-scans; ART 50; 512 A-scans each; 3.5 ×
3.5mm). A built-in semi-automated segmentation tool
(Spectralis software version 6.7.13.0, Eye Explorer software
version 1.9.14.0) followed by manual correction from quali-
fied users (P.M., A.N.S.) was used to obtain the IRL, INL,
and OPL thicknesses. A 1.0, 2.22, 3.45mm circular grid
was placed over the ONH and the average thickness of all
the sections, excluding the center (due to excessive noise),
was obtained for the OCT measurements. Both eyes were
examined and each scan was assessed for sufficient signal
strength, adequate illumination, and accurate beam place-
ment. All scans had a quality of at least 20 dB. OCT exami-
nations occurred on the same day or days prior to
sacrificing the mice for ex-vivo analysis. Each mouse re-
ceived OCT examinations longitudinally at four out of the
seven different following time points: baseline (prior to
EAE induction; n = 11), 7 days post immunisation (dpi;
EAE: n = 5, control: n = 3), 9 dpi (EAE: n = 5, control: n =
3), 11 dpi (EAE: n = 5, control: n = 2), 15 dpi (EAE: n = 3),
20 dpi (EAE: n = 4, control: n = 3), and 28 dpi (EAE: n = 7,
control: n = 2).
Immunofluorescence
Optic nerves and eyes were extracted and fixed for 4 h in
4% paraformaldehyde (in PBS) at 4 °C. The eyes were sepa-
rated from the optic nerve and pre-embedded in 2% agar-
ose gel for better positioning. The eyes and optic nerves
were dehydrated using the LOGOS J Microwave Hybrid
Tissue Processor (Milestone SRL, Bergamo, Italy) and then
embedded into paraffin blocks. Five micron thick retinal
sections were cut dorso-ventrally through the ONH (in-
cluding a small segment of the optic nerve) and 5 μm thick
longitudinal optic nerve sections were cut using a Microm
HM 355S Rotary Microtome with a STS Section-Transfer-
System (Thermo Fisher Scientific, Waltham, MS, USA).
For immunostaining, sections were heated to 60 °C for
1 h, washed several times in xylene, followed by rehydra-
tion with a series of decreasing ethanol concentrations.
For some primary antibodies (see Table 1), unmasking
was performed with sodium citrate buffer pH 6.0 (10
mM sodium citrate, 0.05% Tween 20) at 90 °C for 20
min, followed by 2 washes for 5 min with distilled water
and then one wash for 5 min in PBS. All sections were
incubated with blocking solution (3% normal goat serum
in PBS/ 0.3% Triton X-100 or 2% horse serum in PBS/
0.2% TritonX-100) for 1 h at room temperature. Primary
antibodies (Table 1) were applied in blocking solution
overnight at 4 °C. Slides were washed 3 times with PBS
and incubated with anti-mouse or anti-rabbit Alexa
Fluor 568 or 488 (Thermo Fisher Scientific, Waltham,
MA, USA; 1:500) or anti-goat Cy3-conjugated secondary
antibodies (Jackson Immuno Research, Soham, UK; 1:
500) in blocking solution for 1 h at room temperature.
Slides were then washed two times with PBS, and nuclei
were counter stained with 4′, 6-diamidino-2-phenylin-
dole (DAPI) in PBS for 6 min at room temperature.
Following the last wash, slides were mounted and ana-
lyzed using a fluorescent microscope (Zeiss, Axioplan
Feldbach, Switzerland) and a confocal microscope (Leica
TCS SP8, Leica Application Suite X, V 3.1.1.15751, oil
immersion at 63x magnification).
Neuronal nuclei (NEUN) and DAPI stained retinal
sections imaged with the fluorescent microscope were
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stitched into panoramic retinal images in Adobe Photo-
shop CS6 Extended (Adobe Systems, Inc., San Jose, CA,
USA) using the Photomerge function without either
blending or geometric distortion corrections. Counting
of positively labeled NEUN cells co-stained with DAPI
was performed by two investigators (P.M., A.N.S.)
blinded to subject information, including group assign-
ment of each animal. An average of the two investigators
NEUN positive cell count was used for the statistical
analysis. For immunofluorescence, mice were sacrificed
7 dpi (EAE: n = 3, control: n = 1), 9 dpi (EAE: n = 3, con-
trol: n = 1), 11 dpi (EAE: n = 3, control: n = 1), 15 dpi
(EAE: n = 3, control: n = 1), 20 dpi (EAE: n = 3, control:
n = 1), 28 dpi (EAE: n = 3, control: n = 2), and 33 dpi
(EAE: n = 2, control: n = 2).
TUNEL assay
Terminal deoxynucleotidyl transferase mediated dUTP
nick-end labelling (TUNEL) was performed according to
the manufacturer’s recommendations (Roche Diagnos-
tics, Rotkreuz, Switzerland) on 5 μm paraffin retinal sec-
tions to detect RGC death. Immunofluorescent signals
were analyzed with a digital microscope (Zeiss, Axioplan
Feldbach, Switzerland) and all RGCs positive for TUNEL
were counted at each time point. For the TUNEL stain-
ing, retinal sections were obtained from 2 healthy
controls and from EAE mice at 9 dpi (n = 1), 11 dpi (n =
1), 15 dpi (n = 2), 20 dpi (n = 2), 28 dpi (n = 2), and 33
dpi (n = 2).
RNA isolation and semi-quantitative real-time polymerase
chain reaction
Retinas were isolated through a slit in the cornea, frozen
in liquid nitrogen and stored at − 80 °C. Total RNA was
extracted using an RNA isolation kit (NucleoSpin;
Macherey-Nagel) including a DNAse treatment to remove
residual genomic DNA. 1 μg of RNA, oligo(dT) and M-
MLV reverse transcriptase (Promega, Fitchburg, WI,
USA) were used to prepare cDNA. To analyze gene ex-
pression by real-time PCR, 10 ng of cDNA template were
amplified using a polymerase chain reaction (PCR) poly-
merase ready mix (PowerUp Syber Green Master Mix,
Thermo Fisher Scientific), specific primer pairs (Table 2),
and a thermocycler (ABI QuantStudio 3, Thermo Fisher).
Expression levels were normalized to β-actin (Actb) and
relative expression was calculated with the ThermoFisher
software using the comparative threshold cycle method
(ΔΔCT) and control samples for calibration [42]. The
healthy controls from all time points were grouped to-
gether for analysis. The mice in each group and the time
points assessed with real-time PCR were the same as the
ones included for the immunofluorescence assessment in
Section 2.3. The eyes and optic nerves from each mouse
were randomly pre-assigned for either immunofluores-
cence or real-time PCR analysis.
Histology for light and electron microscopy
To evaluate retinal and optic nerve morphology, eyes
and optic nerves were enucleated and fixed in 2.5% glu-
taraldehyde in cacodylate buffer (pH 7.2, 0.1M) over-
night at 4 °C. For the eyes, the cornea and lens were
removed and by cutting through the ONH, the nasal
and temporal halves of the eyecups were separated. For
the optic nerve, the anterior portion was sectioned for
cross-sectional segments and the posterior part was sec-
tioned for longitudinal segments. All the samples were
washed in cacodylate buffer twice for 15 min and incu-
bated in 1% osmium tetroxide in cacodylate buffer for 1
h. The samples were then dehydrated in a series of in-
creasing ethanol concentrations and embedded in Epon
812 plastic with propylene oxide. Semi-thin sections
(0.5 μm) were counterstained with methylene blue and
Table 1 Primary antibodies used for immunofluorescence
Antigen Host Dil. HIER Catalog No. Company
Glial fibrillary acidic protein (GFAP) Mouse 1:500 Yes G-3893 Sigma, St Louis, USA
Allograft inflammatory factor 1 (IBA1) Rabbit 1:250 Yes 019–19741 Wako, Neuss, Germany
Neurofilament-M (NEFM) Mouse 1:500 No RMO-270 Thermo Fisher Scientific, Waltham, USA
CD3 Rabbit 1:100 Yes NB600–1441 Novus Biologicals, Littleton, USA
Albumin (ALB) Rabbit 1:500 No RARaAlb Nordic Immunology, Tilburg, Netherlands
Myelin basic protein (MBP) Rabbit 1:1000 No ab216668 Abcam, Cambridge, UK
Neuronal nuclei (NEUN) Mouse 1:250 No MAB377 Merck Millipore, Billerica, USA
Glutamine synthetase (GS) Mouse 1:250 Yes MAB302 Merck Millipore, Billerica, USA
Alzheimer precursor protein (APP) Mouse 1:100 Yes MAB348 Merck Millipore, Billerica, USA
Aquaporin-4 (AQP4) Goat 1:250 No sc-9888 Santa Cruz Biotechnology, USA
Transmembrane protein 119 (TMEM119) Rabbit 1:200 Yes G-9264 Sigma, St Louis, USA
CD68 Mouse 1:100 Yes MAB1435 Merck Millipore, Billerica, USA
HIER heat-induced epitope retrieval, Dil. Dilution
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analyzed by light microscopy (Axioplan; Zeiss, Jena,
Germany).
Ultra-thin sections (100 nm) were cut and transferred
onto silicon wafers. They were stained with an alcoholic
solution of 2% uranyl acetate and Reynolds lead citrate
in sodium hydroxide. The sections were scanned using a
Zeiss Merlin ultra-high resolution field emission scan-
ning electron microscope (Zeiss, Oberkochen) at 2 kV
acceleration voltage and a beam current of 400pA with
the Everhart-Thornley-Detector. The mosaic image was
acquired via an ATLAS 5 System (Zeiss, Oberkochen).
Stitching was done with TrakEM2, a FIJI plugin [43] and
was exported as PNG for further analysis. All electron
microscopy images have a resolution of 8 nm per pixel.
Morphological structure of the optic nerve and retinal
sections were assessed qualitatively. For histology, mice
were sacrificed 7 dpi (EAE: n = 3, control: n = 2), 11 dpi
(EAE: n = 3), and 28 dpi (EAE: n = 4, control: n = 2).
Statistical analysis
Statistical analysis was performed using R: a language
and environment for statistical computing (R Core
Team, 2016, V: 1.1.453; https://www.r-project.org/). For
OCT measurements, a linear mixed effects model (func-
tion lmer in library lme4, V 1.1–17) was used to account
for intra-subject, inter-eye dependencies with group and
time points as covariates. The residuals of the model
were assessed for normality using Q-Q plots (function
qqnorm in default core R library) and histograms (func-
tion hist in default core R library) to ensure the model
fit the data properly. The least squares mean test (func-
tion emmeans in library emmeans, V1.2.4) revealed the
differences between specific comparisons and included a
Bonferroni correction for multiple comparisons. Based
on these models, we assessed the differences between
study groups at each time point. For the NEUN cell
count, an ANOVA (function lm in default core R library)
was used to assess the differences between EAE and
healthy controls at each time point. Pairwise comparisons
incorporating Bonferroni correction (function emmeans
in library emmeans, V1.2.4) were completed to evaluate
differences between specific comparisons. For real-time
PCR analysis, statistical differences between EAE and
healthy controls at different time points was calculated
using ANOVA (function lm in default core R library) and
corrected for multiple comparisons using Bonferroni-
Holm correction (function p.adjust in default core R li-
brary). p-values equal to or below 0.05 were taken to be
statistically significant for all measurements.
Results
Clinical assessment
Initial body weight loss was observed in EAE mice 10
days after immunisation, with the greatest decline de-
tected at peak of disease (15 dpi), followed by a gradual
weight increase until the final observation time point
(Fig. 1a). Clinical symptoms began with onset of motor im-
pairment at 11 dpi, peak of disability at 15 dpi, partial re-
covery of symptoms by 20 dpi, followed by stabilization of
symptoms until the final observational time point (Fig. 1b).
OCT detected retinal changes in EAE and healthy mice
In our previous study [11], IRL thickness was examined
at baseline, 11, 15, and 28 dpi according to expected
changes in EAE scores. The current study included add-
itional time points (7, 9, and 20 dpi) to determine when
first signs of structural retinal alterations are observed
and to further characterize IRL thickness changes over
time. IRL thickness in healthy control mice remained
constant and within error limits throughout the observa-
tional period. Similarly, IRL thickness of EAE mice at
baseline (mean ± SD: 70.27 ± 1.13 μm) was not statisti-
cally different from healthy controls at baseline (70.81 ±
0.56 μm). First signs of IRL thickening in EAE mice were
observed at 11 dpi (76.65 ± 3.55 μm, p = 0.001) but not at
prior time points, while a statistically significant decrease
was detected at 28 dpi (63.14 ± 2.83 μm, p = 0.00002) com-
pared to healthy controls at baseline (Fig. 2). In comparison
Table 2 Primers used for real-time PCR
Gene Forward (5′-3′) Reverse (5′-3′) Product (bp)
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153
Pou4f1 (Brn3a) CGCCGCTGCAGAGCAACCTCTT TGGTACGTGGCGTCCGGCTT 130
Bdnf CAAAGCCACAATGTTCCACCAG GATGTCGTCGTCAGACCTCTCG 213
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138
Mcp1 (Ccl2) GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT 108
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240
Il1b ACTACAGGCTCCGAGATGA CGTTGCTTGGTTCTCCTTG 141
Tnf CCACGCTCTTCTGTCTACTGA GGCCATAGAACTGATGAGAGG 92
Aqp4 TACTGGAGCCAGCATGAATC CCACATCAGGACAGAAGACA 149
Rlbp1 (Cralbp) CCTTTCCAGTCGGGACAAGTATG GGGTTTCCTCATTTTCCAGCAG 140
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to baseline values in EAE mice, IRL significantly increased
in thickness until 11 dpi (p < 0.00001), and significantly
decreased at 20 dpi (66.47 ± 2.47 μm, p = 0.0003) as well as
at 28 dpi (p < 0.00001; Fig. 2a). However, the outer retinal
layers that were not examined in our prior study, exhibited
no statistically significant difference in INL or OPL thick-
ness between EAE and healthy control mice (Fig. 2b). The
means and SD of all OCT measurements can be found in
Table 3.
Evaluating blood-retinal-barrier (BRB) disruption
To characterize the histopathological basis underlying
these OCT findings, extensive ex-vivo analysis was per-
formed at various time points in both the retina and optic
nerve. Firstly, signs of BRB disruption were assessed with
albumin immunostaining in retinal samples. Diffuse albu-
min staining was observed outside and around blood ves-
sels in the retinal superior vascular plexus of EAE mice at
9 dpi and 11 dpi, but not at later time points compared to
healthy controls (Additional file 1). In healthy controls, al-
bumin was present only within the blood vessels at all
time points (Additional file 1).
Microglial and astroglial response in the retina and optic
nerve
To delineate the microglial response throughout the dis-
ease course, allograft inflammatory factor 1 (IBA1) stain-
ing was performed in retinal and optic nerve samples.
Increased microglial cell presence was observed as early
as 7 dpi in both the retina and optic nerve and persisted
until the final observational time point (Fig. 3a and c).
The microglial response was more pronounced in the
optic nerve compared to the retina (Fig. 3a and c). In
the optic nerve, the greatest presentation of microglial
cells occurred at 11 dpi, coinciding with extensive cellu-
lar infiltration (as illustrated by the increase in the num-
ber of nuclei stained with DAPI; Fig. 3a). To assess if the
microglial cells observed early on in the disease were
resident microglia, optic nerve sections were stained for
transmembrane protein 119 (TMEM119; Fig. 3b) [44].
Based on the TMEM119 staining, an increased number
of resident microglia was observed in the optic nerve of
EAE mice as early as 7 dpi, which intensified further at
11 dpi (Fig. 3b).
To assess the astroglial response, glial fibrillary acidic
protein (GFAP) staining was also performed in healthy
control and EAE mice. Increased astrocytosis was first
observed at 9 dpi, subsequent to microglial activity, and
also persisted until 33 dpi in both the retina and optic
nerve of EAE mice (Fig. 4a and b). A strong appearance
of astrogliosis was observed in the retina of EAE mice
(Fig. 4b). The strong glial response in the retina was cor-
roborated by the significantly higher mRNA expression
of Gfap at 11 dpi (2-fold increase, p = 0.02), 15 dpi (7-
fold increase, p < 0.00001), and 20 dpi (6-fold increase,
p < 0.00001), while tapering off at 28 dpi (4-fold increase,
p < 0.00001), and 33 dpi (3-fold increase, p = 0.0002) in
EAE mice compared to healthy controls (Fig. 4c).
Further inflammatory responses in EAE
T-cell presence was investigated, since it plays a signifi-
cant role in pathogenesis and tissue damage in animal
models of MS [18]. First signs of T-cells (CD3) appeared
at 11 dpi along with extensive cellular infiltration (ob-
served via DAPI nuclei staining) in the optic nerves of
EAE mice (Fig. 5a). Infiltrating cells appeared to
accumulate near the ONH but were also observed
throughout the optic nerve in EAE mice (Fig. 5a). T-cell
Fig. 1 Clinical assessment of healthy and EAE induced C57BL/6 J mice. a Body weight over the observational period for both healthy
control C57BL/6 J (black) and EAE induced (grey) mice, mean ± SD. b EAE clinical scores longitudinally in EAE induced mice, mean ± SD.
EAE: experimental autoimmune encephalomyelitis.
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presence diminished thereafter, but remained evident
until 33 dpi in EAE mice (Fig. 5a). There was no sign of
T-cells in the retina at any time point (Fig. 5b). Previous
studies have also reported little to no T-cell or macro-
phage infiltration of the retina in these experimental ON
models [45]. To explore other signs of inflammatory re-
sponse in the retina, immune cell and inflammatory
markers were analyzed with real-time PCR. We first ex-
amined expression of Tnf (tumor necrosis factor), which
was amplified at 20 dpi (2-fold increase), 28 dpi (2-fold
increase), and significantly increased at 33 dpi (4-fold
increase, p = 0.001) in EAE compared to healthy controls
(Fig. 5c). Tnf is activated by microglia as well as astro-
cytes and involved in acute-phase immune-mediated in-
jury [46], which appears to play a role in EAE retinal
pathology. Retinal expression of Mcp1 (monocyte
chemoattractant protein 1, also known as Ccl2; impli-
cated in mediating monocyte recruitment) significantly
increased at 15 dpi (10-fold increase, p = 0.001), and 20
dpi (14-fold increase, p = 0.00003), tapering off from 28
dpi (9-fold increase, p = 0.002) until 33 dpi in EAE mice
(Fig. 5d). There was also a significant increase in Casp1
Fig. 2 Inner retinal layer thickness increased at onset and decreased at later time points in EAE. a Boxplots of the inner retinal layer
(IRL) thickness over time in EAE (yellow) and healthy controls (blue). b Optical coherence tomography retinal B-scan of healthy C57BL/
6 J mouse with segmented layers including the IRL, inner nuclear layer and outer plexiform layer. Inset includes a diagram of the IRL
composed of retinal ganglion cells (RGC). The retinal nerve fiber layer consists of the unmyelinated axons of the RGCs, with their cell
bodies and dendrites located within the ganglion cell layer and inner plexiform layer respectively. * p-values for comparison between
EAE and control mice (**** p < 0.00001, *** p < 0.0001), § p-value for comparison between baseline and recovery in EAE mice (§§§§
p < 0.00001). EAE: experimental autoimmune encephalomyelitis, dpi: days post immunisation. Scale bars: 200 μm
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(Caspase-1) expression at 15 dpi (2-fold increase, p =
0.004), 20 dpi (3-fold increase, p < 0.00001), 28 dpi (2.5-
fold increase, p = 0.0004), and 33 dpi (2-fold increase,
p = 0.003) in EAE retinas compared to healthy controls
(Fig. 5e). Caspase-1 plays a pivotal role in the apoptotic
cascade [47]. The mRNA expression of Il1β (Interleukin-
1β), produced by microglia and is a target of caspase-1,
was not statistically different at any time point (Fig. 5f ).
Demyelination and axonal pathology
Initial signs of demyelination (loss of MBP), a key factor im-
plicated in MS and EAE pathology, were observed in the
optic nerve of EAE mice at 11 dpi progressing until 33 dpi,
at which the greatest loss of immunoreactivity was detected
(Fig. 6a). Furthermore, the observation of speckles at the
final observational time point (dpi 33) in EAE mice might
indicate myelin debris or disorganized remyelination fol-
lowing disruption (Fig. 6a). Neurofilament-M (NEFM) im-
munoreactivity decreased concurrently with MBP from 11
dpi until 33 dpi, associated with profound axonal degener-
ation in the optic nerve of EAE mice (Fig. 6b). In the retina,
NEFM decrease in the IRL was observed later than in the
optic nerve; beginning at 20 dpi and persisting until the
final observational time point in EAE mice compared to
healthy controls (Fig. 6d). NEFM decrease was also de-
tected in the outer plexiform layer of EAE mice from 20 to
33 dpi (Fig. 6d). To assess other markers of axonal impair-
ment, amyloid precursor protein (APP; involved in axonal
transport) was investigated and observed to increase as
early as 9 dpi and persevered until 33 dpi in both EAE optic
nerves and retinas (Fig. 6c and e).
Neurodegeneration and RGC deterioration
Subsequent to demyelination and axonal degeneration,
downstream RGC damage was expected [48]. Along
these lines, there was a significant decrease in the num-
ber of NEUN positive cells labelling neurons (primarily
RGCs) at 11 dpi (242.0 ± 26.2, p = 0.02), 15 dpi (239.3 ±
27.1, p = 0.02), 20 dpi (194.0 ± 22.9, p = 0.0004), 28 dpi
(149.0 ± 36.5, p = 0.00002), and 33 dpi (169.0 ± 8.5, p =
0.0002) in EAE mice compared to healthy controls
(336.3 ± 16.4; Fig. 7a/b). The presence of TUNEL positive
cells in the ganglion cell layer (GCL; Fig. 7c) confirmed
the occurrence of apoptosis at 15 dpi to 33 dpi in EAE
mice. Pou4f1 (POU class 4 homeobox 1, also known as
Brn3a), a transcription factor expressed in neurons
including RGCs [49], was first amplified significantly at 7
(2-fold increase, p = 0.01), and 9 dpi (2-fold increase, p =
0.01) – possibly due to compensatory mechanisms of the
cell – then decreased from 20 (2-fold decrease) to 33 dpi
(3-fold decrease) when damage had accumulated in EAE
mice (Fig. 7d). Bdnf (brain-derived neurotrophic factor;
important for neuronal survival [50]), decreased in expres-
sion significantly at 20 dpi (6-fold decrease, p = 0.03), and
marginally at 28 (3-fold decrease) and 33 dpi (2-fold de-
crease) in EAE mice, further revealing the presence of a
neurotoxic environment within the retina (Fig. 7e).
Müller cell reactivity
The role Müller cells play in EAE retinal pathology has
been relatively unexplored. First, we assessed aquaporin-
4 (AQP4; found abundantly on Müller cells) using im-
munostaining, which had a signal decrease at 15 and 28
dpi, specifically in the IRL of EAE mice compared to
healthy controls (Fig. 8a). mRNA expression of Aqp4 in
the retina decreased specifically at 15 dpi (1.5-fold de-
crease) in EAE mice compared to healthy controls, how-
ever, this did not reach statistical significance after
correction for multiple comparisons (p = 0.04 uncor-
rected, p = 0.3 corrected; Fig. 8c). The intensity of glu-
tamine synthetase (GS) staining, also found on Müller
cell processes, appeared to decrease at 15 and 20 dpi
with some recovery by 28 dpi in EAE mice compared to
healthy controls (Fig. 8b). Finally, Rlbp1 (retinaldehyde
binding protein 1, also known as Cralbp), expressed in
Müller cells, significantly decreased in expression only at
15 (1.5-fold decrease, p = 0.05) and 20 dpi (1.5-fold de-
crease, p = 0.05) in EAE retinas (Fig. 8d).
Table 3 Mean values of each optical coherence tomography measurement along with the standard deviation in parentheses for
healthy controls and EAE mice at each time point
Time
points
IRL (μm) INL (μm) OPL (μm)
Control EAE Control EAE Control EAE
Baseline 70.81 (0.56) 70.27 (1.12) 23.31 (1.93) 22.88 (2.95) 21.02 (0.62) 20.05 (1.17)
7 DPI 71.06 (0.60) 72.36 (0.91) 22.10 (2.39) 22.58 (1.37) 19.75 (0.59) 18.81 (1.54)
9 DPI 70.90 (0.33) 71.83 (2.34) 21.35 (2.17) 22.08 (2.86) 19.31 (0.47) 19.59 (1.39)
11 DPI 70.50 (0.43) 76.65 (3.55) 22.16 (2.65) 21.05 (1.36) 20.94 (0.52) 19.59 (1.21)
15 DPI NA 72.85 (2.33) NA 20.83 (1.23) NA 19.88 (0.77)
20 DPI 70.50 (0.55) 66.47 (2.47) 21.52 (1.87) 21.69 (2.94) 19.63 (0.78) 19.89 (2.20)
28 DPI 71.03 (0.56) 63.14 (2.83) 22.22 (2.40) 22.67 (2.66) 21.06 (0.51) 19.86 (1.66)
EAE experimental autoimmune encephalomyelitis, IRL inner retinal layer, INL inner nuclear layer, OPL outer plexiform layer, DPI days post immunisation, NA
not applicable
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Histological assessment
Since signs of axonal degeneration (i.e. NEFM and APP
staining) and demyelination (i.e. MBP staining) was ob-
served in the optic nerve, histological morphology was
evaluated with light and electron microscopy at 7, 11,
and 28 dpi. In cross-sectional optic nerve sections, the
pial septa that surrounds the axon bundles appears to be
disrupted at both 11 and 28 dpi in EAE mice (Fig. 9a).
Furthermore, irregular myelination, thinner myelin sheaths,
and a high proportion of unmyelinated axons can be ob-
served at 28 dpi in EAE mice (Fig. 9a) similar to the demye-
lination observed with MBP staining (Fig. 6b). In the
longitudinal optic nerve sections, a disruption of axonal
organization was observed, and the space within the axons
appeared to be enlarged at 11 and 28 dpi (Fig. 9b). The
scanning electron micrographs of the optic nerve revealed
more detailed insight into the pathological changes ob-
served in EAE mice. In healthy controls, nerve fibres were
Fig. 3 Microgliosis presented early in EAE and persisted until the final observational time point. Increased microglial cell (IBA1) presence was
observed as early as 7 days post immunisation (dpi) in both the a/b optic nerve and d retina (arrows), persisting until the final observational time
point in EAE mice. b TMEM119 marked resident microglial cells observed at 7 dpi and 11 dpi in EAE mice, a while in the optic nerve, a significant
increase in microglial cells at 11 dpi also coincided with cellular infiltration. The insets a/c display examples of microglial cells in controls
(ramified: weak signal, long branched processes) and EAE mice (amoeboid: strong signal, round)
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densely packed with a combination of large and small fibres
throughout the optic nerve (Fig. 9c-e). At 11 dpi, optic
nerve pathology (including demyelination and degenerated
axons) appeared to begin near the perimeter of the optic
nerve cross-sections (Fig. 9d) and to a lesser extent around
the blood vessels (Fig. 9e). By 28 dpi, severe degeneration
was observed completely from the perimeter to the centre
of the optic nerve in EAE mice (Fig. 9c). The early path-
ology at the perimeter of the optic nerve cross-sections
may be caused by inflammatory cells such as T-cells passing
from the cerebral spinal fluid (which surrounds the entirety
of the optic nerve) through the pial septa, which has also
been observed in ON patients [51]. Infiltrating immune
cells can also contribute to local pathology around the
blood vessels following vascular leakage.
While, there was heterogeneity in the EAE mice at 11
dpi, a substantial number of optic nerve fibres exhibited
signs of swelling (Fig. 10b-d) compared to healthy con-
trols (Fig. 10a). Numerous fibres with large myelin
balloons, likely filled with fluid, were found at 11 dpi
(Fig. 10b). Similarly at 28 dpi, myelin ballooning was ob-
served, although the effect was less pronounced than at
11 dpi (Fig. 10f ). Initial signs of axonal degeneration in-
cluded accumulation of mitochondria and lysosomes
within the axoplasm of several axons (Fig. 10e/h/j), with
considerably more nerve fibres affected by 28 dpi. In
some cases, accumulation of neurofilaments could be
observed in the dense axoplasm of fibres, indicating an-
other form of axonal degeneration (Fig. 10d). Nerve
fibres with dark cytoplasm indicated even further deteri-
oration of the axons, which appeared enlarged with
vacuoles at 11 dpi (Fig. 10c) and shrunken at 28 dpi
(Fig. 10g). Numerous fibres with empty myelin sheaths
were found at 28 dpi (Fig. 10i) indicating complete
axonal degeneration. Usually these axons were sur-
rounded by thicker than normal myelin sheaths, likely a
product of repeated remyelination in an attempt to re-
pair (Fig. 10i). This remyelination was redundant and de-
fective in the EAE optic nerve at 11 and 28 dpi (Fig. 10e/k)
and may possibly be associated with the myelin speckles
observed in Fig. 6a.
No gross notable changes were observed in the ret-
inal morphology using light microscopy in EAE mice
(Additional file 2A) contrasting the OCT-derived IRL
thickness changes observed in EAE mice. A possible
explanation is that fixation by default decreases fluids,
therefore, it is difficult to observe and evaluate swell-
ing using histological assessment. Previous studies
have also observed little evidence for alterations in
histological retinal thickness in EAE mice including
measurements of the total retinal thickness, inner
plexiform layer, INL and OPL [9, 52]. Nonetheless,
electron microscopy of the retina showed neuronal
cell bodies with dark cytoplasm and numerous vacu-
oles (likely indicating degeneration) in the GCL at 11
and 28 dpi in EAE mice (Additional file 2B), corrob-
orating the findings of apoptosis with TUNEL staining
(Fig. 7c).
Discussion
The aim of this study was to add morphological sub-
strate to OCT-derived retinal measurements using ex-
Fig. 4 Astrocytosis appeared subsequent to microgliosis in EAE and also persisted until the final time point. Increased GFAP signal (associated
with gliosis) presented at 9 dpi and also remained until 33 dpi in both the a optic nerve and the b retina (arrows). c mRNA expression of Gfap in
EAE retinas significantly increased from 11 dpi to 33 dpi, tapering off at the final two observational time points. p-values for comparison between
EAE and control mice (**** p < 0.00001, *** p < 0.0001, * p < 0.05). EAE: experimental autoimmune encephalomyelitis, GFAP: glial fibrillary acidic
protein, IRL: inner retinal layer, INL: inner nuclear layer, ONL: outer nuclear layer
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vivo analysis of retinal and optic nerve tissue and to ex-
plore the biological mechanisms of visual pathway dam-
age in EAE mice. Fitting with previous assumptions,
inflammation and edema were largely associated with
IRL thickening at clinical onset of experimental ON.
Signs of early retinal pathology (i.e. APP increase and
changes in Pou4f1 expression) were observed, and pre-
ceded IRL thinning at the earlier time points. In fact, the
inflammatory edema-induced IRL thickening may over-
shadow any thinning generated by early retinal degener-
ation, at least until inflammation subsides partially and the
accumulation of sustained neuro-axonal damage becomes
considerable. The early glial response (including microglia
and astrocyte activation) in the retina prior to inflammatory
demyelination in the optic nerve may contribute to primary
retinal pathology.
Furthermore, Müller cell reactivity was observed in the
IRL, subsequent to early astrogliosis and recovered at later
time points. It is also clear that rapid retrograde degener-
ation following ON played a substantial role in IRL thin-
ning: damage in the optic nerve was followed by signs of
axonal degeneration (i.e. NEFM decrease) in the retina. Fi-
nally, the accumulating effects of the sustained neuro-
axonal damage, inflammatory mediated demyelination, and
Fig. 5 A strong inflammatory response was observed in the optic nerve and retina of EAE mice. a T-cells (CD3) initially appear 11 days
post immunisation (dpi) along with the cellular infiltration (DAPI), subsiding at later time points but still remaining until 33 dpi in the
optic nerve of EAE mice. b T-cells were not observed in the retina of EAE mice at any time point. Yet, c Tnf expression amplified
from 20 to 33 dpi in EAE compared to healthy controls in the retina. Tnf is a proinflammatory cytokine involved in the innate
immune response. Whereas, d mRNA expression of Mcp1 in the retina increased significantly between 15 dpi and 28 dpi in EAE mice.
Mcp1 likely plays an amplifying role (rather than an initiating role) in EAE. e Caspase 1 (Casp1) increases significantly from 15 dpi to
33 dpi in EAE retinas. It has a crucial role in development of immune mediated inflammatory processes leading to central nervous
system demyelination. However, f Il-1β, which is a cytokine activated by Caspase 1, was not different in retinal expression between
EAE mice and healthy controls. p-values for comparison between EAE and control mice (**** p < 0.00001, *** p < 0.0001, ** p < 0.01).
EAE: experimental autoimmune encephalomyelitis, TNF: tumor necrosis factor, MCP1: monocyte chemoattractant protein 1, IL-1β:
interleukin-1β, IRL: inner retinal layer, INL: inner nuclear layer, ONL: outer nuclear layer. EAE: experimental autoimmune
encephalomyelitis, IBA1: allograft inflammatory factor 1, TMEM119: transmembrane protein 119, IRL: inner retinal layer, INL: inner
nuclear layer, ONL: outer nuclear layer
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Fig. 6 (See legend on next page.)
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Fig. 6 Demyelination and axonal pathology was perceived in both the retina and optic nerve in EAE. a Demyelination (MBP) in the optic nerve
was first observed 11 days post immunisation (dpi) progressing until 33 dpi where profound signs of myelin disorganisation and possible myelin
debris were observed. b Axonal degeneration (NEFM) was observed from 11 dpi until 33 dpi in the optic nerve of EAE mice. c APP, important for
axonal transport, appears to increase as early as 9 dpi and also persisted until the final observational time point in EAE optic nerve sections. In the
retina, d NEFM appears to decrease in the IRL (arrows) and in the outer plexiform layer over time in EAE mice; beginning later (20 dpi) than in
the optic nerve. e APP in the retina appears to increase (arrows) as early as 9 dpi similar to presentation in the optic nerve for EAE mice. EAE:
experimental autoimmune encephalomyelitis, MBP: myelin basic protein, NEFM: neurofilament-M, APP: Alzheimer precursor protein, IRL: inner
retinal layer, INL: inner nuclear layer, ONL: outer nuclear layer
Fig. 7 Neurodegeneration in the retina was observed throughout the observational period in EAE. a-b The number of NEUN positive cells decreased
significantly from 11 days post immunisation (dpi) to 33 dpi in EAE mice compared to healthy controls. Furthermore, c apoptosis was observed using
TUNEL staining from 20 to 33 dpi in the ganglion cell layer (arrows) of EAE mice. d Pou4f1, a transcription factor expressed in retinal ganglion cells first
increased significantly at 7 and 9 dpi (possibly due to compensatory mechanisms within the cell) followed by a decrease from 20 to 33 dpi. e Bdnf
retinal expression, which is an important neurotrophic factor for neuronal survival, also decreased at 20 and 28 dpi in EAE mice compared to healthy
control, further exemplifying neurodegeneration. p-values for comparison between EAE and control mice (*** p < 0.0001, ** p < 0.01, * p < 0.05). EAE:
experimental autoimmune encephalomyelitis, NEUN: neuronal nuclei, TUNEL: terminal deoxynucleotidyl transferase dUTP nick end labelling, IRL: inner
retinal layer, POU4F1: POU domain class 4 transcription factor 1, BDNF: brain-derived neurotrophic factor, INL: inner nuclear layer, ONL: outer
nuclear layer
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glial pathology likely contributed to the significant IRL thin-
ning observed at the final observational time point.
Inflammatory edema substantially contributes to IRL
thickening at clinical onset of experimental ON
The increased IRL thickness at early time points (Fig. 2a)
coincides with the significant inflammatory response ob-
served in both the retina and optic nerve. Early microglial
activation and astrogliosis in both the retina and optic
nerve (Figs. 3-4), followed by extensive cellular infiltration
(including T-cells) in the optic nerve at 11 dpi (Fig. 5),
likely further amplified the inflammatory process within
the retina, potentially contributing to the acute IRL thick-
ening. Since astrogliosis was present in EAE mice, it
is possible that astroglial end-feet dysfunction can re-
sult in retinal water imbalance and BRB impairment
(observed concurrently at 9 dpi; Additional file 1),
which has also been associated with vasogenic edema
[53, 54]. Furthermore, impaired astrocyte end-feet and
the swollen cell bodies can result in extensive gaps in
Fig. 8 Müller cell reactivity was detected following signs of optic neuritis. a A decrease in AQP4 signal (arrows) in the retinal nerve fibre layer was
observed 15 and 28 days post immunisation (dpi) in the retina of EAE mice. b Glutamine synthetase, expressed in Müller cells, decreased in the
Müller cell branched processes at 15 and 20 dpi but appeared to recover by 28 dpi in EAE mice. Arrows in the healthy control retina point to
intact Müller cell processes, while in EAE, the arrows indicate the recovered processes that appear disorganized. c mRNA expression of Aqp4
decreased only at 15 dpi, while d Rlbp1 expression decreased significantly at 15 and 20 dpi in EAE mice retinas compared to healthy controls. p-
values for comparison between EAE and control mice (* p < 0.05). EAE: experimental autoimmune encephalomyelitis, AQP4: aquaporin-4, RLBP1:
retinaldehyde-binding protein 1, IRL: inner retinal layer, INL: inner nuclear layer, ONL: outer nuclear layer
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Fig. 9 Optic nerve pathology began near the perimeter and blood vessels and progressed into the center. In the optic nerve a-b, the fibres that
surround the axon bundles appear to be disrupted by 11 days post immunisation (dpi) in EAE mice. a There was also a reduction in the number of
axons present in EAE mice compared to healthy controls at 11 dpi and 28 dpi in the optic nerve. b In the longitudinal optic nerve sections, an overall
disruption of axonal organisation was observed in EAE mice. c-e Scanning electron micrographs of cross-sectional optic nerves in healthy and EAE
mice provide a closer look. c In central sections, signs of axonal degeneration were first observed 11 dpi, while at 28 dpi severe pathology was present
throughout the entire optic nerve. d Near the perimeter of the optic nerve sections, strong axonal degeneration was observed at both 11 and 28 dpi
in EAE mice compared to healthy controls. Severe loss of axons and large empty spaces were also observed at 28 dpi near the perimeter of the optic
nerve. e Some demyelinated axons were observed along with axonal degeneration at 11 dpi near blood vessels, while at 28 dpi severe axonal loss
was present in EAE mice compared to healthy controls. Red arrows: demyelinated axons, DA: degenerating axon, E: empty myelin sheath with no
axon, Oligo: oligodendrocyte, EAE: experimental autoimmune encephalomyelitis. Electron micrograph image resolution: 8 nm/pixel
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Fig. 10 (See legend on next page.)
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the pial septa and glial limitans, as observed in EAE
optic nerve sections at 11 dpi (Fig. 9). Disruption to
the connective tissue and glial fibers that surround the
axon bundles may also add to optic nerve swelling via
extracellular edema. The inflammatory changes in the or-
bital subarachnoid spaces of the ONH could contribute to
the edema. Since the ONH lacks the classical characteris-
tics of the blood-brain-barrier, it can allow non-specific
permeability and be more vulnerable to damage [51]. Infil-
tration of peripheral inflammatory cells at 11 dpi in the
optic nerve were predominantly observed near the ONH,
possibly contributing to swelling of the IRL observed on
OCT. Also, it is feasible that optic nerve axonal swelling
(as observed by electron micrographs at 11 dpi) could
propagate backwards into the retina contributing to the
increased IRL thickness observed at 11 dpi in EAE mice.
A combination of both edema and a strong inflammatory
response likely resulted in the overall IRL thickening ob-
served early in EAE.
Early retinal pathology prior to cellular infiltration or
immune-mediated demyelination of the optic nerve
While demyelination in the optic nerve occurred con-
currently with axon damage at 11 dpi, it does not seem
to be a prerequisite for retinal neuro-axonal degener-
ation in EAE mice. The increase in APP signal indicated
early axonal transport impairment in both the retina and
optic nerve, preceding the loss of structural integrity to
the axons themselves as reflected by the decrease in
NEFM (Fig. 6). Moreover, Pou4f1 upregulation in the
early stages of EAE (possibly occurring below a certain
threshold of neuronal damage) might activate endogen-
ous compensatory mechanisms within RGCs and is an-
other sign of early RGC pathology (Fig. 7d). Previous
studies have also reported RGC loss prior to inflamma-
tory infiltration, demyelination, or edema of the optic
nerve [17, 55–57]. In line with reports by other authors
[3], we found that early signs of RGC pathology precedes
IRL thinning, suggesting that neuronal damage may occur,
at least partially, independent of apparent inflammation.
Despite the clear indication of early neuro-degenerative
processes occurring in EAE, the net initial structural re-
sponse was IRL thickening. This apparent discrepancy is
probably a consequence of the severe inflammatory re-
sponse and subsequent swelling, outweighing the contribu-
tion of early stage neurodegeneration. Once inflammation
and edema have subsided, the effects of ongoing neuro-
axonal degeneration may manifest as a reduction of IRL
thickness.
Retrograde degeneration plays a significant role in IRL
thinning
The observed temporal dynamics of RGC damage
suggest that secondary neuro-axonal injury (following
inflammation-induced demyelination) is a principal
mechanism involved in retinal pathology. In particular,
axonal damage (assessed by NEFM) appeared later in
the retina compared to the optic nerve (Fig. 6). Likewise,
DNA degradation (TUNEL staining), indicative of cell
loss via apoptosis, was observed only at later time points
(Fig. 7c). Electron microscopy cross-sectional images
provided further support for retrograde degeneration;
indicating significant deterioration in the optic nerve,
beginning at the perimeter (11 dpi) and progressing into
the centre by 28 dpi, where the highest density of axonal
bundles exists (Fig. 9). In line with our findings, previous
studies suggested that axonal damage, possibly via retro-
grade degeneration, results in apoptosis of RGCs after
clinical manifestation of the disease [2, 45, 51, 56]. Thus,
retrograde degeneration following ON is likely an im-
portant factor contributing to IRL thinning observed at
the final time points.
Neuro-axonal degeneration throughout the entire disease
course contributes to IRL thinning at later stages
In addition to retrograde degeneration, overall IRL thin-
ning in EAE mice is seemingly further enhanced by a
net combination of the sustained neuro-axonal degener-
ation, inflammatory-mediated demyelination, and glial
pathology. Once significant sections of myelin or axon
have deteriorated, the RGC body itself is likely to die,
and the decrease in OCT-derived IRL thickness at later
(See figure on previous page.)
Fig. 10 Examples of optic nerve pathology observed in EAE mice 11 and 28 days post immunisation. a Example of a healthy axonal fibre with
normal myelination. b Swollen nerve fibres with a fragment of axon left and a large balloon produced from the splitting of the myelin sheaths
was observed in EAE mice at 11 dpi. c Another large swollen nerve fibre with dark cytoplasm (likely a sign of severe degeneration) filled with
numerous vacuoles at 11 dpi. d Many bloated myelinated axons were observed at 11 dpi with a dense axoplasm filled with primarily
neurofilament. e A dystrophic axon where the axoplasm contains an accumulation of lysosomes. Redundant myelination can also be found
around the axons at 11 dpi. f In EAE mice at 28 dpi, ballooning was also observed in some nerve fibres. g Nerve fibres with dark cytoplasm were
identified at 28 dpi as well but appeared more shrunken than at 11 dpi. h At 28 dpi, large myelinated nerve fibres showed dense degeneration
with numerous vacuoles and organelles within the cytoplasm, however they were not as large as fibres at 11 dpi. i Empty myelin sheaths with
completely degenerated axons were visible at 28 dpi in EAE mice. j Dystrophic axons were also found at 28 dpi. k Redundant myelin was more
common at 28 dpi, often forming around tiny fragments of axons or entirely on its own. v: vacuoles, m: mitochondria, EAE: experimental
autoimmune encephalomyelitis. Electron micrograph image resolution: 8 nm/pixel
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time points might reflect neuronal in addition to axonal
degeneration. Although signs of remyelinated optic
nerve axons were observed (Fig. 6a/10), it appeared
irregular and redundant in nature. The observed myelin
debris can be processed through the autophagy-lysosome
pathway, promoting further inflammation, [58] possibly
contributing further to the fibrotic scar formation that
was observed in the optic nerve (Fig. 9). Additional IRL
damage was likely promoted by increased expression of
Casp1 (Fig. 5e) and decreased expression of Bdnf (Fig. 7e)
in EAE at later time points. Since BDNF is involved in an-
terograde fast axonal transport [59], the reduction in Bdnf
expression observed in our study may contribute to add-
itional axonal transport failure in EAE mice. Damage in
the early phase of the disease (likely driven by a local
inflammatory response, i.e. astrocytes and resident micro-
glia) compounds with late stage disease activity (i.e. accu-
mulating inflammatory effect and further primary and
secondary neuro-axonal damage), thereby accelerating
IRL thinning in the late stages of the disease.
Gliosis observed prior to immune-mediated
demyelination and its involvement in early retinal
pathology
There was evidence for an early inflammatory response
from resident microglial cells (stained with TMEM119) ob-
served prior to vascular leakage in EAE (Fig. 3). A signifi-
cantly greater number of microglial cells were present in
the optic nerve than in the retina, likely due to the optic
nerve being one of the primary sites of injury in this experi-
mental ON model. Previous studies suggested that resident
microglia was only weakly activated, whereas infiltrating
macrophages are highly immunoreactive [60]. This is com-
plementary to the current findings of a weaker microglial
response in the retina compared to the optic nerve, as there
was a lack of evidence for cellular infiltration (including T-
cells) in the retina at any time point (Fig. 5b).
Since early signs of astrogliosis were also detected sub-
sequent to microglial activation, it is possible that astro-
cytes were activated by resident microglial cells prior to
signs of ON and cellular infiltration. Previous studies
have also suggested that CD68+ activated microglia and
macrophages (also observed in this study, not shown)
could be potent inducers of the A1 astroglial phenotype;
important for the pro-inflammatory response [53]. An-
other possibility is astrocyte activation via damage to the
end-foot processes that surround the vasculature, or as a
result of signaling products from the periphery released
into the retina following albumin leakage, detected con-
currently at 9 dpi in the retina (Additional file 1). Earlier
studies have also observed BRB leakage early in the dis-
ease course [2, 61–63]. It is likely a combination of both
microglial activation and vascular abnormalities that ini-
tiate the early astrocytic response in the retina.
This initial local inflammatory response could con-
tribute to the observed primary retinal pathology.
Activated microglia quickly proliferate and engage in
phagocytosis of cellular debris, which may be a re-
sponse to early retinal disturbances but can also
generate further inadvertent primary pathology [64].
It has been suggested that the production of oxida-
tive species by astrocytes, along with other inflam-
matory mediators, may contribute to neuro-axonal
damage [65]. Tnf expression which increased in EAE
mice (Fig. 5c), can contribute to synaptic deficits in
addition to inducing neuronal cell death by controlling
the release of glutamate from astrocytes [66–69]. While,
Mcp1 (Fig. 5d), that may be released by both astrocytes
and microglia, is involved in mediating immunopathology
and likely has an amplifying, rather than an initiating role
[67, 70–72], promoting further retinal damage.
Müller cell reactivity during EAE retinal pathology
Müller cells appeared to undergo location- and time-
specific structural changes in EAE mice, as reflected by a
decrease in Rlbp1 mRNA expression and GS immuno-
staining in EAE mice at 15 and 20 dpi. Since the basal
end-feet of Müller cells form adherent junctions with as-
trocytes, the previously noted early astroglial pathology
in the retina may also induce Müller cell reactivity at
these later time points. Inflammatory mediated demye-
lination of the optic nerve was observed at 11 dpi prior
to Müller glial susceptibility, thus it is also possible that
Müller cells are responding to this inflammation and
early RGC pathology. Aquaporin-4 is a water channel lo-
cated on Müller cells near the BRB [18, 73], and de-
creased expression in EAE mice at 15 dpi along with
Rlbp1, further supports the time specific changes ob-
served in Müller cells. Müller cells may react to the
swelling observed at 11 dpi (Fig. 2a/10) by a subsequent
downregulation of Aqp4 as a protective mechanism
against uncontrolled propagation of edema [74]. While
GS, found primarily on Müller cells, is involved in regu-
lating extracellular glutamate levels, and disruption of
this process can result in excitotoxicity of ganglion cells
[75]. Müller cells appear to respond to optic nerve injury
by rapidly translocating GS to the region closest to the
site of injury [75]. The decrease in GS signal also likely in-
dicates the inability of this retinal glia to sustain its physio-
logical maintenance role. Once the inflammatory response
subsided at later time points (Figs. 3-5), Müller cell re-
activity also decreased as observed by the recovery in
Rlbp1 expression and GS immunostaining (Fig. 8). In
terms of locality, GS immunostaining revealed that these
changes were most predominantly located in the Müller
cell processes that span the inner plexiform layer (Fig. 8b),
while, aquaporin-4 loss was observed specifically in the
pRNFL (Fig. 8a). Since retinal pathology in this
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experimental ON model was primarily observed in the
IRL, Müller cells may be more reactive in this region.
Nonetheless, Müller glia disruption could contribute to
the overall decrease in IRL thickness observed over time,
since they are involved in modulating neuronal activity,
maintaining retinal homeostasis, and providing metabolic
support to RGCs [75].
INL, similar to previous reports [29], and OPL thick-
ness did not change over time in EAE mice compared to
healthy controls. In MS patients, INL thickening has
been observed and is usually associated with ON or
microcystic macular edema [76, 77]. This thickening is
speculated to be due to intracellular edema caused by
Müller mediated AQP4 reactivity or KIR4.1 dysfunction
[78, 79], however, direct evidence for this has not been
confirmed in the mouse model of MS. The lack of OCT-
derived INL or OPL thickness difference in EAE may be
because these layers are especially thin and difficult to
accurately segment in mice (since current methods of
segmentation involve a significant amount of manual
correction). It may also indicate that pathology in this
experimental ON model is primarily restricted to the
IRL, including the IRL-specific Müller cell reactivity ob-
served here. Taken together, these data provide new evi-
dence for Müller cell reactivity that is 1) temporally
specific to 15 and 20 dpi with signs of recovery at later
time points, and 2) spatially specific to the IRL; respond-
ing to early inflammation and subsequent RGC path-
ology with compensatory mechanisms.
Limitations
A small sample size of animals was assessed at each time
point for the ex-vivo analysis. Therefore future studies
should evaluate the significant findings from this study
with more replicates to further confirm the results ob-
served. Our study lacked a CFA-only control group to
assess whether the effects of neuro-axonal degeneration
observed are MOG-specific. However, previous studies
assessing optic nerve and retinal pathology in auto-
immune ON reported little to no difference between the
CFA-only group and healthy controls in inflammatory
pathology and neuro-axonal degeneration [2, 57]. Our
results suggests that IRL changes in EAE are primarily
influenced by pRNFL changes over time; yet previous
OCT studies investigating pRNFL changes in EAE mice
report contradictory findings [3, 32]. This may be due to
the use of different species and immunisation protocols,
but also because of methodological limitations as the
pRNFL is a relatively thin structure in rodents and thus
difficult to segment accurately on its own. More recent
studies, including this report, addressed this problem by
aggregating the pRNFL, GCL and inner plexiform layer
into one structure, the IRL [11, 16, 31]. This may pro-
vide a more robust measure of EAE-induced pathology
and has been reported to have excellent test-retest reli-
ability [11].
Conclusion
This descriptive study provides cellular and molecular
insight into the possible mechanisms leading to ON and
underlying structural changes of the retina in EAE mice.
Findings in this mouse model correspond nicely with struc-
tural changes observed in patients suffering from MS-re-
lated acute-ON [6]. The initial transient IRL thickening
coincides with signs of edema and with the significant in-
flammatory response detected at clinical onset of experi-
mental ON. Effects of early retinal damage (prior to
inflammation mediated demyelination in the optic nerve)
on OCT-derived IRL measurements were likely outweighed
by the significant swelling at earlier time points. Yet, the oc-
currence of early retinal degenerative pathology highlights
the need for neuroprotective or -regenerative treatment of
ON, since interventions applied at a later, or more chronic
stage may not revert the possibly irreversible neuro-axonal
damage that occurred initially. Pre-clinical trials targeting
inflammatory mechanisms of retinal damage may consider
11 dpi as a useful OCT study check-point. Although retro-
grade mediated damage following ON appears to be a
major mechanism leading to RGC degeneration, early path-
ology due to microglial activation, and astrocytosis may
have contributed to IRL atrophy as well. Early inflammation
appears to instigate Müller cell reactivity that may provide
support to the retina during injury. Future studies should
explore the neuroprotective role of Müller cells in experi-
mental ON. Additionally, mechanistic studies assessing the
role of Müller cells should be performed in the context of
both MS, but also neuromyelitis optica spectrum disorder,
where AQP4-mediated Müller pathology has been impli-
cated [80, 81]. Following a reduction of the inflammatory
response, neuro-axonal impairment became more visible in
OCT readouts: earlier retinal damage accumulated with
continued neuro-axonal degeneration and resulted in the
severe IRL thinning observed at the final observational time
point. These late OCT time points are suitable for testing
interventions specifically targeting neurodegeneration.
Moreover, the results in this study may be useful for sample
size calculations with these end points in mind. Prospective
studies may assess the relatively unexplored outer retinal
layers in EAE, which have been reported to be dysfunc-
tional in MS patients even in the absence of structural
damage [82]. Overall, OCT measures of changes in
IRL thickness in the mouse model of experimental
ON can be rationalized in the context of cellular
and molecular changes related to neuro-axonal path-
ology derived from immunohistochemical analysis.
Furthermore, OCT may be useful for assessing
pharmacological responses in pre-clinical trials for
treatments targeting neurodegeneration in MS.
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Additional files
Additional file 1: Vascular leakage was observed early in the retina of EAE
mice. Signs of vascular leakage in the retina were observed at both 9 and
11 dpi in EAE mice compared to healthy controls but were not seen at
earlier or later time points. (PDF 6155 kb)
Additional file 2: Retinal degeneration was observed in the ganglion
cell layer in EAE mice. (A) No notable gross changes were observed in
EAE retinal light micrographs (B) scanning electron micrographs of
retinal sections in healthy and EAE mice. In the retina, degeneration
of cell bodies in the ganglion cell layer was observed at 11 and 28
dpi. (PDF 5034 kb)
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